|
|
|
Royal Pharmaceutical Society of Great Britain and APS, Royal Pharmaceutical Society of Great Britain, 1 Lambeth High St, London
10/03/2008
OUTLINE PROGRAMME Conference chair: Professor Michael Heinrich, University of London, UK • Cannabis research fi fty years on Professor Raphael Mechoulam, The Hebrew University of Jerusalem, Israel • The multiple roles of endocannabinoids Dr Vincenzo di Marzo, Endocannabinoid Research Group (Italian National Research Council), Italy • Cannabis derived natural products Professor Giovanni Appendino, Università del Piemonte Orientale, Italy • Metabolomics approaches in cannabis research Dr Arno Hazekamp, University of Leiden, Netherlands • Cannabis-derived medicines in the treatment of chronic infl ammatory conditions Dr José Prieto and Professor Michael Heinrich, University of London, UK • The Cannabinoid Receptors - where do they lead us? Professor David Baker, University of London, UK • Clinical research on cannabis derived medicines Professor John Zajicek, Peninsula Medical School and Derriford Hospital, UK • Safety of cannabis-based medicines Professor Rudolf Brenneisen, University of Bern, Switzerland
|
|
|
|
|
|
Organized by:
|
|
Royal Pharmaceutical Society of Great Britain |
|
Invited Speakers:
|
|
see website
|
|
|
|
|
|
Deadline for Abstracts:
|
|
ASAP
|
|
|
|
|
|
Registration:
|
|
Registration fees: £125 for members of Royal Pharmaceutical Society or Academy of Pharmaceutical Sciences or £140 for non-members (fees inclusive of lunch, refreshments and course documentation). We are pleased to offer a special rate of £50 for students (please provide evidence of being a student)
|
|
E-mail:
|
|
science@rpsgb.org
|
|
|
|
|
|
|
|